Share page on LinkedIn

Adaptive clinical trials

Adaptive clinical trials can reduce time-to-market and cut development costs

Using adaptive design to optimise product development at the programme and portfolio level

Using adaptive design to optimise product development at the programme and portfolio level

This whitepaper provides insight into adopting an adaptive design strategy at the level of the product portfolio. It has been written to help senior R&D decision-makers understand the critical role of adaptive design in portfolio decision-making and in appreciating the value that this approach can bring.

Download the whitepaper
Adaptive design for medical devices: The faster path to market

Adaptive design for medical devices: The faster path to market

An adaptive design clinical trial can help to create a stronger value proposition for your medical device and give you a competitive edge, by reducing development costs and accelerating time-to-market.

Adaptive design allows for pre-set interim analyses to assess efficacy, treatment effect and other critical data, allowing you to make better, more informed development decisions.

ICON experts have more than a decade of experience in the design, simulation and execution of adaptive design trials. Our operational teams and specialised technologies enable medical device manufacturers to apply the power of adaptive design.

Read the whitepaper

Latest on adaptive trial design

If you would like to receive our adaptive trials email updates, including the latest on adaptive trial design, visit our preference centre and select adaptive design.

Receive adaptive trials email updates

Adaptive trials solutions

ICON offers a range of services to help achieve the best possible adaptive trial. These solutions includes the analysis and review of adaptive trial strategies across a portfolio of development products and the provision of oversight for ongoing adaptive trials.

Adaptive trials services